Piboserod
编号: 92301
Cas号: 152811-62-6
纯度: 98%
Piboserod , also known as SB-207266, is a selective 5-HT4 receptor antagonist which was marketed and manufactured by GlaxoSmithKline under the trade name Serlipet for the management of atrial fibrillation and irritable bowel syndrome.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | Piboserod |
|---|---|
| Iupac 化学名称 | N-((1-Butyl-4-piperidyl)-methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide |
| 同义词 | SB-207266; SB 207266; SB207266 |
| 英文同义词 | SB-207266; SB 207266; SB207266 |
| 分子式 | C22H31N3O2 |
| 分子量 | 369.509 |
| Smile | O=C(C1=C(OCCC2)N2C3=C1C=CC=C3)NCC4CCN(CCCC)CC4 |
| InChiKey | KVCSJPATKXABRQ-UHFFFAOYSA-N |
| InChi | InChI=1S/C22H31N3O2/c1-2-3-11-24-13-9-17(10-14-24)16-23-21(26)20-18-7-4-5-8-19(18)25-12-6-15-27-22(20)25/h4-5,7-8,17H,2-3,6,9-16H2,1H3,(H,23,26) |
| Cas号 | 152811-62-6 |
| 相关CAS号 |
订购信息
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |
